Net income decreased 37.7%
Net income changed -37.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed -37.7% from the comparable as-filed period.
Cash & equivalents changed +17.8% from the comparable as-filed period.
Gross margin changed -246 basis points from the comparable as-filed period.
Selling, general & administrative changed -4.2% from the comparable as-filed period.
Gross profit changed -7.6% from the comparable as-filed period.
Operating margin changed -89 basis points from the comparable as-filed period.
Research & development changed -5.4% from the comparable as-filed period.
Inventory changed -0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Operating income changed -4.6% from the comparable as-filed period.
Revenue changed +0.3% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.